ClinicalTrials.Veeva

Menu

Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Completed

Conditions

Severe Sepsis
Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT00541827
assente

Details and patient eligibility

About

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients. Secondary aims are to clarify the pathogenesis and the clinical relevance of mitochondrial damage during sepsis.

Full description

The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients, as compared to otherwise healthy surgical ones. In order to better clarify the pathogenesis of mitochondrial dysfunction during sepsis, cardiogenic shock patients (suffering from systemic hypoperfusion) will act as additional controls. Markers of oxidative stress will be measured in tissue samples from septic patients. The clinical relevance of mitochondrial dysfunction during sepsis will be assessed in terms of both skeletal muscle and platelet function.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Consecutive ICU-admitted severely septic or septic shock patients.

Exclusion criteria

  • Severe thrombocytopenia.
  • Severe coagulopathy.
  • Pre-existing mitochondrial disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems